ArticleBMC cancer2023
Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling.
Jian Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBMC cancer2023
Jian Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.